Want to join the conversation?
$STX 4Q15 Q&A: Fox of Cross Research requested some color on the non-HDD business. Phil replied that overall the quarter proceeded as expected. Flash business, particularly in PCIe business, continues to be up strong and a growth driver, and STX going forward expects to continue to work to improve operational performance of the business, added Phil
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.